These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 5686110)
21. [The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)]. Baĭsogolov GD; Shakhtarina SV; Afanasova NV Med Radiol (Mosk); 1991; 36(8):4-7. PubMed ID: 1890940 [TBL] [Abstract][Full Text] [Related]
22. [Radiation pericarditis following treatment of lymphogranulomatosis]. Baĭsogolov GD; Shishkin IP; Shapiro IB Med Radiol (Mosk); 1983 Sep; 28(9):27-31. PubMed ID: 6688649 [TBL] [Abstract][Full Text] [Related]
23. [Indirect endolymphatic chemotherapy of patients with lymphoma]. Kindzel'skiĭ LP; Gubareva AA Vrach Delo; 1989 Jun; (6):64-6. PubMed ID: 2781767 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of recurrences of lymphogranulomatosis]. Kovryzhkina TA Med Radiol (Mosk); 1984 Jan; 29(1):35-9. PubMed ID: 6546406 [No Abstract] [Full Text] [Related]
25. [The treatment of lymphogranulomatosis and the problem of its curability]. Heilmeyer L; Musshoff K Munch Med Wochenschr; 1967 Oct; 109(41):2109-14. PubMed ID: 5631693 [No Abstract] [Full Text] [Related]
26. Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: A Haematologist's Perspective. Follows GA Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):457-9. PubMed ID: 26071896 [No Abstract] [Full Text] [Related]
27. [Causes for failures in the treatment of localized forms of lymphogranulomatosis]. Pakulina LE; Chekharina EA Vopr Onkol; 1973 May; 19(5):36-41. PubMed ID: 4714734 [No Abstract] [Full Text] [Related]
28. [Functional state of the liver in lymphogranulomatosis during drug and radiation treatment]. Danova LA; Filov VA Vopr Onkol; 1972; 18(10):43-7. PubMed ID: 4662532 [No Abstract] [Full Text] [Related]
29. [Experience with the treatment of malignant lymphomas using large single doses of Endoxan]. Libánský J; Lukásová M Vnitr Lek; 1967 Jan; 13(1):30-8. PubMed ID: 6043593 [No Abstract] [Full Text] [Related]
30. Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: Have We Got the Balance Right? Illidge T Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):454-6. PubMed ID: 26108883 [No Abstract] [Full Text] [Related]
31. [High dosage cyclophosphamide therapy of malignant diseases in childhood]. Hempel HC; Grimm J; Naumann UR Kinderarztl Prax; 1968 Oct; 36(10):447-54. PubMed ID: 5715803 [No Abstract] [Full Text] [Related]
33. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Carbone PP; Spurr C; Schneiderman M; Scotto J; Holland JF; Shnider B Cancer Res; 1968 May; 28(5):811-22. PubMed ID: 4870882 [No Abstract] [Full Text] [Related]
34. [N-nitrosomethylurea in the chemotherapy of lymphogranulomatosis]. Vermel' AE; Korman NP; Magagina GE; Raevskiĭ IG Vopr Onkol; 1974; 20(3):8-13. PubMed ID: 4439805 [No Abstract] [Full Text] [Related]
35. [Changes in the lungs in patients with lymphogranulomatosis, Stages I-II, following combination therapy]. Baĭsogolov GD; Afanasova NV; Khmelevskaia ZI; Shakhtarina SV Med Radiol (Mosk); 1985 Mar; 30(3):18-22. PubMed ID: 3838568 [TBL] [Abstract][Full Text] [Related]